Leaflet MEDAXONE 2g powder for injection / infusion solution


Indicated for: bacterial infections

Substance: ceftriaxone (cephalosporin antibiotic)

ATC: J01DD04 (Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins)

Ceftriaxone is a third-generation cephalosporin antibiotic used to treat severe bacterial infections, including meningitis, pneumonia, intra-abdominal infections, urinary tract infections, and sepsis. It is effective against a wide range of gram-negative and gram-positive bacteria.

The medication is administered intravenously or intramuscularly, and the dosage is adjusted based on the severity of the infection, the patient's weight, and renal function. Ceftriaxone is frequently used in hospitals for complicated infections or for patients at high risk of severe infections.

Patients should be closely monitored during treatment to detect potential side effects, such as allergic reactions, diarrhea, or liver toxicity. It is important for patients to complete the treatment as directed by their doctor.

Side effects may include nausea, diarrhea, skin rashes, or, in rare cases, severe reactions such as anaphylactic shock or hematological disorders. Patients should inform their doctor of any unusual symptoms.

General data about MEDAXONE 2g

  • Substance: ceftriaxone
  • Date of last drug list: 01-05-2026
  • Commercial code: W42544001
  • Concentration: 2g
  • Pharmaceutical form: powder for injection / infusion solution
  • Quantity: 10
  • Product type: generic
  • Price: 136.68 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: MEDOCHEMIE LTD. - CIPRU
  • Holder: MEDOCHEMIE LTD. - CIPRU
  • Number: 9251/2016/01
  • Shelf life: 3 years-after packing for marketing;after reconstitution-it is used immediately

Concentrations available for ceftriaxone

  • 0.5g
  • 1000mg
  • 1g
  • 250mg
  • 2g
  • 500mg

Compensation lists for MEDAXONE 2g Medochemie

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

136.68 RON

136.68 RON

0.00 RON